ArticleFrontiers in pharmacology2022

Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis.

Lloyd Tanner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.